Search Orphan Drug Designations and Approvals
-
Generic Name: | N-acetylprocainamide |
---|---|
Date Designated: | 03/23/1990 |
Orphan Designation: | To lower the defibrillation energy requirement sufficiently to allow automatic implantable cardioverter defibrillator therapy in those patients who could otherwise not use the device. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Medco Research, Inc. 8455 Beverly Blvd. Suite 308 Los Angeles, California 90048 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-